Literature DB >> 19366691

Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.

Li-Jin Hsu1, Lori Schultz, Qunying Hong, Kris Van Moer, John Heath, Meng-Yen Li, Feng-Jie Lai, Sing-Ru Lin, Ming-Hui Lee, Cheng-Peng Lo, Yee-Shin Lin, Shur-Tzu Chen, Nan-Shan Chang.   

Abstract

Transforming growth factor beta (TGF-beta) initiates multiple signal pathways and activates many downstream kinases. Here, we determined that TGF-beta1 bound cell surface hyaluronidase Hyal-2 on microvilli in type II TGF-beta receptor-deficient HCT116 cells, as determined by immunoelectron microscopy. This binding resulted in recruitment of proapoptotic WOX1 (also named WWOX or FOR) and formation of Hyal-2.WOX1 complexes for relocation to the nuclei. TGF-beta1 strengthened the binding of the catalytic domain of Hyal-2 with the N-terminal Tyr-33-phosphorylated WW domain of WOX1, as determined by time lapse fluorescence resonance energy transfer analysis in live cells, co-immunoprecipitation, and yeast two-hybrid domain/domain mapping. In promoter activation assay, ectopic WOX1 or Hyal-2 alone increased the promoter activity driven by Smad. In combination, WOX1 and Hyal-2 dramatically enhanced the promoter activation (8-9-fold increases), which subsequently led to cell death (>95% of promoter-activated cells). TGF-beta1 supports L929 fibroblast growth. In contrast, transiently overexpressed WOX1 and Hyal-2 sensitized L929 to TGF-beta1-induced apoptosis. Together, TGF-beta1 invokes a novel signaling by engaging cell surface Hyal-2 and recruiting WOX1 for regulating the activation of Smad-driven promoter, thereby controlling cell growth and death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366691      PMCID: PMC2708898          DOI: 10.1074/jbc.M806688200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression.

Authors:  Nan-Shan Chang
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

Review 2.  The WW domain: linking cell signalling to the membrane cytoskeleton.

Authors:  Jane L Ilsley; Marius Sudol; Steven J Winder
Journal:  Cell Signal       Date:  2002-03       Impact factor: 4.315

3.  Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment.

Authors:  J I Chuang; S T Chen; Y H Chang; L S Jen
Journal:  J Chem Neuroanat       Date:  2001-05       Impact factor: 3.052

4.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.

Authors:  A K Bednarek; C L Keck-Waggoner; R L Daniel; K J Laflin; P L Bergsagel; K Kiguchi; A J Brenner; C M Aldaz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

5.  Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.

Authors:  N S Chang; N Pratt; J Heath; L Schultz; D Sleve; G B Carey; N Zevotek
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

6.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.

Authors:  S K Rai; F M Duh; V Vigdorovich; A Danilkovitch-Miagkova; M I Lerman; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.

Authors:  K Ried; M Finnis; L Hobson; M Mangelsdorf; S Dayan; J K Nancarrow; E Woollatt; G Kremmidiotis; A Gardner; D Venter; E Baker; R I Richards
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

8.  Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

Authors:  Keltouma Driouch; Hans Prydz; Rossana Monese; Henning Johansen; Rosette Lidereau; Eirik Frengen
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

9.  Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.

Authors:  Lilly Y W Bourguignon; Patrick A Singleton; Hongbo Zhu; Bo Zhou
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.

Authors:  Nan-Shan Chang
Journal:  BMC Cell Biol       Date:  2002-04-03       Impact factor: 4.241

View more
  50 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  Zfra induction of memory anticancer response via a novel immune cell.

Authors:  Wan-Pei Su; Wan-Jan Wang; Chun-I Sze; Nan-Shan Chang
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

3.  Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.

Authors:  Sara Del Mare; Kyle C Kurek; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  Am J Cancer Res       Date:  2011-04-03       Impact factor: 6.166

Review 4.  Bubbling cell death: A hot air balloon released from the nucleus in the cold.

Authors:  Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-12

Review 5.  Tyrosine phosphorylation of WW proteins.

Authors:  Nina Reuven; Matan Shanzer; Yosef Shaul
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-26

Review 6.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

Review 7.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

8.  Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions.

Authors:  Cecile Duterme; Jeannine Mertens-Strijthagen; Markku Tammi; Bruno Flamion
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

Review 9.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.

Authors:  Meng-Yen Li; Feng-Jie Lai; Li-Jin Hsu; Chen-Peng Lo; Ching-Li Cheng; Sing-Ru Lin; Ming-Hui Lee; Jean-Yun Chang; Dudekula Subhan; Ming-Shu Tsai; Chun-I Sze; Subbiah Pugazhenthi; Nan-Shan Chang; Shur-Tzu Chen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.